Research indicates that certain statins, particularly atorvastatin and simvastatin, may elevate the risk of erectile ...
TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant schizophrenia. The Phase 2 ...
A recent study is raising new questions about whether cannabis-derived compounds could one day play a role in liver care.
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer healthcare company behind the erectile dysfunction gel Eroxon, ...
It might seem like semantics. But whether a health condition qualifies as a disease can have a huge impact on patient experiences and treatment options.
Interim analysis to be conducted under an FDA- and EMA-agreed protocol. Ramat Gan, Israel, July 06, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: C ...
Alzheimer’s blood test breakthrough: 34 circular RNA biomarkers validated in nearly 2,400 patients outperform the pTau217 ...
Predominantly third-line pancreatic cancer patients demonstrated durable survival despite advanced disease; patient who received Namodenoson as second-line therapy remains alive more than 18 months ...
Researchers at Monash University have identified a promising new approach to tackling Alzheimer's disease. In laboratory studies, they found that a copper-based drug not only reduced the buildup ...
Neurocrine Biosciences, Inc. stays a Buy as Ingrezza, Crenessity, and Vykat drive 44% revenue growth; see valuation, patents ...
Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...
Periodontitis remains a major global health challenge, but better outcomes depend on consensus in diagnosis, collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results